XML 78 R63.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Earnings per share (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2022
Text block [abstract] |
Summary of earnings per share |
|  | 2022 A$’000 |  |  | 2021 A$’000 |  |  | 2020 A$’000 |
Loss after income tax attributable to the owners of Kazia Therapeutics Limited |  |  | (24,648 | ) |  |  | (8,422 | ) |  |  | (12,467 | )
Loss after income tax attributable to the owners of Kazia Therapeutics Limited |  |  | (24,648 | ) |  |  | (8,422 | ) |  |  | (12,467 | )
|  | Number |  |  | Number |  |  | Number |
Weighted average number of ordinary shares used in calculating basic earnings per share |  |  | 132,467,686 |  |  |  | 117,674,543 |  |  |  | 73,053,514 |
Weighted average number of ordinary shares used in calculating Diluted earnings per share |  |  | 132,467,686 |  |  |  | 117,674,543 |  |  |  | 73,053,514 |
|  | Cents |  |  | Cents |  |  | Cents |
Basic earnings per share |  |  | (18.61 | ) |  |  | (7.16 | ) |  |  | (17.07 | )
Diluted earnings per share |  |  | (18.61 | ) |  |  | (7.16 | ) |  |  | (17.07 | )

X
- Definition The disclosure of earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 33 -IssueDate 2021-01-01 -Paragraph 66 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_EarningsPerShareExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Text block [abstract] + References No definition available. + Details
Name: | kzia_TextBlockAbstract
Namespace Prefix: | kzia_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration